Europe Microencapsulation Market Size, Growth, Trends, Report 2023-2032
The Europe microencapsulation market was surpassed at USD 3.71 billion in 2022 and is expected to hit around USD 9.58 billion by 2032, growing at a CAGR of 9.95% from 2023 to 2032.
Key Pointers
Report Scope of the Europe Microencapsulation Market
| Report Coverage | Details |
| Market Size in 2022 | USD 3.71 billion |
| Revenue Forecast by 2032 | USD 9.58 billion |
| Growth rate from 2023 to 2032 | CAGR of 9.95% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Capsulae; LycoRed Group; BASF SE; Balchem; AVEKA Group; Reed Pacific Pty Ltd.; GAT Microencapsulation GmbH; Ronald T. Dodge Co.; Evonik Industries AG; Bayer AG |
The market growth is expected to be driven by the high penetration of technology in the pharmaceutical industry of developed regional economies, including Germany, the UK, France, and Italy.The research-based pharmaceutical industry is a key asset of the European economy and plays a critical role in restoring Europe on the growth trajectory, thereby driving demand for the technology from the pharma sector.Germany, France, the UK, and the Netherlands are considered the most prominent countries within the European functional food market, which is expected to drive the demand for microencapsulation across the food & beverages and nutritional supplements industries over the forecast period.
The presence of major pharmaceutical manufacturers, including Roche, Novartis, GlaxoSmithKline, Sanofi, Novo Nordisk, and Bayer, among several others, has a major impact on driving the demand for the microencapsulation technique in developing novel drug delivery systems. The industry players in the region are often engaged in strategic partnerships with microencapsulation technology users from the end-user industries.
The adoption of microencapsulation technology is anticipated to rise over the forecast period as a result of the increasing significance of organic synthesis in the pharmaceutical industry, which delivers a highly complex combination in contrast to the inorganic approach. By dividing supplied medication doses into smaller units that are distributed over a vast area of the gastrointestinal system, microencapsulation increases absorption by lowering localized drug concentration. These benefits are expected to drive the demand for microencapsulation in the pharmaceutical sector.
Europe has been a key region spearheading innovation in the microencapsulation market and is anticipated to grow at a significant pace in the next seven years. The increasing prominence of functional foods combined with the positive market growth for cutting-edge PCM in Europe is expected to spur the demand for microencapsulation. Cosmetotextile is an emerging application segment for the microencapsulation market across the globe and primarily in Europe.
The demand for microencapsulation technologies in Europe has increased significantly owing to the increasing demand for nutraceuticals and functional food products. Microencapsulation can be used to enhance the stability, shelf-life, and bioavailability of these products. Additionally, the use of microencapsulation to encapsulate drugs, which can improve their stability, reduce toxicity, and provide controlled release, is also anticipated to fuel market growth.
Application Insights
The pharmaceutical & healthcare products application segment led the market and accounted for 66% of the revenue share in 2022. Pharmaceutical manufacturers are competing to develop and commercialize more effective medicines with a high focus on the biotechnology industry. This is a source of many new medical treatments, as well as specialized and personalized treatments, which are expected to have a major impact on the growth of the pharmaceutical & healthcare products segment over the forecast period.
The home & personal care application segment is expected to expand at a CAGR of 12.03% over the forecast period. The region is witnessing extensive investments in the research & development of personal care products. The growing home & personal care industry in Europe, along with the utilization of microencapsulation technology to alter the quality of products such as fragrances & flavors used in perfumes, soaps, lotions, creams, and shampoos, is anticipated to propel the market growth over the forecast period.
The food & beverage application segment is likely to witness a growth rate of 11.43% over the forecast period. The growing trend toward leading a healthy lifestyle, the rising adoption of preventative health management through functional food diets, and improvements to the nutritional value of food products along with taste, color, texture, and aroma, have majorly impacted the demand for microencapsulation technology from the food & beverage industry.
Cosmetotextiles is a technology that combines cosmetics and fabrics via microencapsulation. These textiles perform cosmetic and biological activities such as energizing, slimming, refreshing, vitalizing, skin shining, anti-aging, body care, fitness, and health. Cosmetotextiles provide advantages to the skin, help fight the aging process, and provide a sense of wellness or well-being. Thus, the increasing use of cosmetotextiles is expected to have a major impact on the demand for microencapsulation technology over the forecast period.
Technology Insights
The spray technology segment led the market and accounted for 34% of the revenue share in 2022. Spray technology offers high encapsulation efficiency along with good stability of the finished products. Encapsulation by spray drying and spray cooling technologies is a low-cost commercial process mainly used to encapsulate flavors, fragrances, and oils.
The emulsion segment is expected to witness a CAGR of 10.16% over the forecast period. Emulsion preparation plays a key role in ensuring the efficiency of microencapsulation, owing to the production of probiotic microcapsules. Microfluidic devices and membranes are potential microencapsulation techniques due to their ability to control particle size and work under mild conditions. Owing to the above-mentioned benefits, along with the potential of emulsion technology to ensure the safe delivery of next-generation probiotics, the segment growth is projected to remain strong.
Dripping technology produces microcapsules that are surrounded by wall materials and are produced by a relatively low-temperature entrapping method. The significant benefit of this technology is the extended shelf life of flavorings owing to the provision of an almost impermeable barrier against oxygen. Owing to these benefits, the dripping technology segment is expected to advance healthily over the forecast period.
Microencapsulation by coating technology includes different processes such as fluid bed coating, pan bed coating, and air suspension coating. Certain advantages of the microencapsulation coating technology, such as maximum protection of active materials, flavor, odor masking, and continued & controlled release, are anticipated to boost the segment growth.
Europe Microencapsulation Market Segmentations:
By Application
By Technology
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Europe Microencapsulation Market
5.1. COVID-19 Landscape: Europe Microencapsulation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Europe Microencapsulation Market, By Application
8.1. Europe Microencapsulation Market, by Application, 2023-2032
8.1.1. Pharmaceutical & Healthcare Products
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Home & Personal Care
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Food & Beverages
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Agrochemicals
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Construction
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Textile
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Europe Microencapsulation Market, By Technology
9.1. Europe Microencapsulation Market, by Technology, 2023-2032
9.1.1. Coating
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Emulsion
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Spray Technologies
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Dripping
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Europe Microencapsulation Market, Regional Estimates and Trend Forecast
10.1. Europe
10.1.1. Market Revenue and Forecast, by Application (2020-2032)
10.1.2. Market Revenue and Forecast, by Technology (2020-2032)
Chapter 11. Company Profiles
11.1. Capsulae
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. LycoRed Group
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. BASF SE
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Balchem
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. AVEKA Group
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Reed Pacific Pty Ltd.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GAT Microencapsulation GmbH
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ronald T. Dodge Co.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Evonik Industries AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Bayer AG
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers